MedTrace Logo

Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer

NCT02883582 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-08-30

No results posted yet for this study

Summary

The purpose for the trial is intended to evaluate safety and effectiveness of an oxyhydrogen generator with nebulizer in an adjuvant therapy for patients with severe asthma.

Conditions

Interventions

DEVICE

oxyhydrogen

Hydrogen/oxygen mixed gas inhaled(proportion 2:1),3 L/min . 1 hour each time,twice a day(BID).Test Duration is three months.

DEVICE

oxygen

oxygen inhaled,3 L/min . 1 hour each time,twice a day(BID).Test Duration is three months.

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER

  • Second Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER

  • The Second Hospital of Hebei Medical University

    collaborator OTHER

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Shanghai Asclepius Meditec Inc.

    lead INDUSTRY

Principal Investigators

  • Nanshan Zhong, academician · China, Guangdong First Affiliated Hospital of Guangzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-08-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02883582 on ClinicalTrials.gov